This study investigates the financial burden of out-of-pocket costs for patients with both HIV and hypertension (HTN) in urban and peri-urban Uganda. Through a survey of 94 patients from 10 clinics in Wakiso and Kampala districts, researchers assessed the direct, indirect, and economic costs associated with care. Findings reveal that HTN care costs constitute a higher percentage of household income compared to HIV care, with nearly half of patients spending more than 10% of their income on HTN treatment. The study also highlights that costs were lower during a COVID-19 lockdown, suggesting limited access to care during this period. The study concludes that integrating services for HIV and HTN could help reduce these costs for patients.